Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma

Corresponding Author

Yvonne M. Mowery

Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA

Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, North Carolina, USA

Correspondence: Yvonne M. Mowery, Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.

View original article

0 0 0 0 0 0 0

Comments (0)